Kane Biotech Inc (TSE:KNE)
TSXV:KNE
Canadian Market
Holding TSE:KNE?
Track your performance easily

Kane Biotech (KNE) Income Statement

0 Followers

Kane Biotech Income Statement

Last quarter (Q2 2024), Kane Biotech's total revenue was C$620.44K, an increase of 2045.50% from the same quarter last year. In Q2, Kane Biotech's net income was C$9.18M. See Kane Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ -513.62KC$ 148.98KC$ 156.73KC$ 1.61MC$ 1.34MC$ 1.69M
Cost of Revenue
C$ -348.09KC$ 39.51KC$ 44.70KC$ 1.04MC$ 814.72KC$ 1.08M
Gross Profit
C$ -165.53KC$ 109.47KC$ 112.03KC$ 568.44KC$ 526.86KC$ 609.91K
Operating Expense
C$ 3.93MC$ 3.47MC$ 3.57MC$ 5.45MC$ 4.75MC$ 4.20M
Operating Income
C$ -4.10MC$ -3.36MC$ -3.46MC$ -4.88MC$ -4.22MC$ -3.59M
Net Non Operating Interest Income Expense
C$ -988.27KC$ -1.21MC$ -801.20KC$ 294.13KC$ 83.26KC$ 141.22K
Other Income Expense
-C$ -3.77KC$ 254.90KC$ 327.77KC$ 461.65KC$ 2.77M
Pretax Income
C$ -5.06MC$ -4.56MC$ -4.53MC$ -4.85MC$ -3.85MC$ -960.18K
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
C$ 4.83MC$ -5.03MC$ -4.27MC$ -4.60MC$ -3.72MC$ -960.18K
Basic EPS
C$ 0.04C$ -0.04C$ -0.03C$ -0.04C$ -0.03C$ -0.01
Diluted EPS
C$ 0.03C$ -0.04C$ -0.03C$ -0.04C$ -0.03C$ -0.01
Basic Average Shares
C$ 522.91MC$ 127.12MC$ 120.70MC$ 112.60MC$ 108.61MC$ 82.30M
Diluted Average Shares
C$ 548.58MC$ 127.12MC$ 120.70MC$ 112.60MC$ 108.61MC$ 82.30M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
C$ 3.58MC$ 3.51MC$ 6.03MC$ -6.49MC$ -5.57MC$ -5.28M
Net Income From Continuing And Discontinued Operation
C$ 4.83MC$ -5.03MC$ -4.27MC$ -4.60MC$ -3.72MC$ -960.18K
Normalized Income
C$ -4.41MC$ -3.35MC$ -3.33MC$ -3.56MC$ -2.83MC$ -3.37M
Interest Expense
------
EBIT
C$ -4.10MC$ -3.35MC$ -3.71MC$ -4.43MC$ -3.72MC$ -818.50K
EBITDA
C$ -3.88MC$ -3.11MC$ -3.46MC$ -4.25MC$ -3.65MC$ -764.08K
Currency in CAD

Kane Biotech Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis